| Literature DB >> 26047339 |
Fernanda Cobayashi1, Bárbara Hatzlhoffer Lourenço2, Marly Augusto Cardoso3.
Abstract
Vitamin D is associated with a wide range of other functions beyond bone development. We evaluated the factors associated with 25-hydroxyvitamin D levels in 974 children aged ≤ 10 years and the impact of BsmI polymorphism of the vitamin D receptor (VDR) gene (rs1544410) on metabolic parameters in a subsample (n: 430) with a follow-up 2 years later from the initial population-based cross-sectional study. Multiple linear regression models were used in the analyses. The prevalence (95% CI) of vitamin D deficiency, insufficiency and sufficiency of children was 11.1% (9.2-13.2), 21.8% (19.2-24.5) and 67.2% (64.1-70.1), respectively. Overall, 23% of the variation in serum 25-hydroxyvitamin D concentrations was accounted for by BsmI polymorphism β = -0.053 (95% CI) (-0.100, -0.006), maternal schooling (≥ 9 years) β = 0.100 (0.039, 0.161), serum vitamin E β = 0.478 (0.381, 0.574), total cholesterol concentration β = 0.232 (0.072, 0.393) and serum folate β = 0.064 (0.013, 0.115). BsmI polymorphism was positively associated with HOMA-IR β = 0.122 (0.002, 0.243) and fasting glucose concentration β = 1.696 (0.259, 3.133). In conclusion, variables related to socioeconomic level, the presence of the allele risk for BsmI and other nutrient concentrations were associated with serum 25-hydroxyvitamin D concentrations. Our results suggest that BsmI polymorphism is correlated with metabolic outcomes.Entities:
Keywords: children; genetic polymorphism; insulin resistance; nutrition; vitamin D
Mesh:
Substances:
Year: 2015 PMID: 26047339 PMCID: PMC4490459 DOI: 10.3390/ijms160612531
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Characteristics of children included in the study according to age group (Acrelândia, Brazil, 2007).
| Variables | All ( | <25 Months ( | 25 to <60 Months ( | ≥60 Months ( |
|---|---|---|---|---|
|
| ||||
| Child’s sex | ||||
| Male | 497 (51.0) | 86 (54.4) | 146 (50.9) | 265 (50.1) |
| Race/ethnicity | ||||
| White | 93 (10.3) | 15 (10.1) | 31 (11.5) | 47 (9.8) |
| Black | 45 (5.0) | 8 (5.4) | 11 (4.1) | 26 (5.4) |
| Brown | 762 (84.7) | 126 (84.6) | 228 (84.4) | 408 (84.2) |
| Maternal schooling (<9 years) | 767 (69.2) | 135 (65.8) | 218 (65.3) | 414 (72.6) |
| Low birth weight (<2500 g) | 46 (5.3) | 5 (3.4) | 12 (4.5) | 29 (6.4) |
| Stunting | 49 (5.1) | 17 (11.0) | 12 (4.2) | 20 (4.0) |
| Overweight or obesity | 143 (14.8) | 47 (30.1) | 44 (15.4) | 52 (9.9) |
|
| ||||
| Serum 25-hydroxyvitamin D (nmol/L) | ||||
| Median (IQR) b | 66 (86–105) | 60 (87.5–120) | 61 (85–105) | 69 (87–104) |
| <50 | 108 (11.0) | 23 (14.6) | 39 (13.6) | 46 (8.7) |
| 50–75 | 212 (21.8) | 28 (17.7) | 67 (23.3) | 117 (22.1) |
| ≥75 | 654 (67.2) | 107 (67.7) | 181 (63.1) | 366 (69.2) |
| Serum vitamin A (µmol/L) | ||||
| Median (IQR) b | 0.7 (1.1–1.5) | 0.8 (1.1–1.5) | 0.9 (1.1–1.5) | 0.9 (1.1–1.4) |
| <0.70 | 80 (15.1) | 24 (15.2) | 42 (14.6) | 80 (15.1) |
| Serum vitamin E (µmol/L) | ||||
| Median (IQR) b | 14.4 (17.4–20.9) | 14.7 (18.4–22.6) | 14.3 (17.1–20.6) | 14.4 (17.2–20.6) |
| <11.6 | 85 (8.7) | 19 (12.0) | 27 (9.4) | 39 (7.4) |
| Serum folate (median, nmol/L) | ||||
| ≥23.7 | 463 (47.7) | 73 (46.2) | 136 (47.5) | 254 (48.2) |
| Total cholesterol (mg/dL) | ||||
| Median (IQR) b | 132 (151–172) | 132 (151–180) | 135 (155–175) | 132 (149–168) |
|
| ||||
| C-reactive protein >5 mg/L | 90 (9.4) | 21 (13.5) | 26 (9.4) | 43 (8.2) |
| Diarrhea in the past 15 days | 214 (22.2) | 67 (42.7) | 70 (24.6) | 77 (14.7) |
a Total may be less because of missing values; b IQR, Interquartile ranges.
Vitamin D receptor polymorphisms distribution in 974 children aged <10 years (Acrelândia, Brazil, 2007).
| Gene | SNP | Wild (A) | Mutant (a) | Frequency (%) AA/Aa/aa a |
|---|---|---|---|---|
| FokI | rs2228570 | G | A | 50.3/39.5/10.2 |
| BsmI | rs1544410 | C | T b | 27.9/63.0/9.1 |
| ApaI | rs7975232 | A | C | 24.0/65.8/10.2 |
| TaqαI | rs731236 | A | G | 29.9/61.0/9.1 |
| Cdx2 | rs11568820 | G | A | 27.5/65.3/7.2 |
a Total may be less because of missing values; b Increased risk allele for low serum 25-hydroxyvitamin D concentration according to the present study.
Factors associated with serum 25-hydroxyvitamin D concentrations in urban Amazonian children <10 years old (Acrelândia, Brazil, 2007).
| Serum 25-Hydroxyvitamin D Concentrations (N 974) a | |||||||
|---|---|---|---|---|---|---|---|
| Independent Variables | Crude β-Coefficient | 95% CI | Adjusted β-Coefficient | 95% CI | |||
|
| 0.228 | ||||||
| BsmI (rs1544410) | −0.070 | −0.132, −0.008 | 0.026 | −0.053 | −0.100, −0.006 | 0.025 | |
|
| |||||||
| Maternal schooling (years) | |||||||
| <9 |
|
| |||||
| ≥9 | 0.075 | 0.020, 0.130 | 0.007 | 0.100 | 0.039, 0.161 | 0.001 | |
|
| |||||||
| Serum vitamin E (µmol/L) | 0.538 | 0.466, 0.611 | <0.001 | 0.478 | 0.381, 0.574 | <0.001 | |
| Total cholesterol (mg/dL) | 0.640 | 0.506, 0.774 | <0.001 | 0.232 | 0.072, 0.393 | 0.005 | |
| Serum folate (median, nmol/L) | |||||||
| <23.6 |
|
| |||||
| ≥23.6 | 0.062 | 0.012, 0.112 | 0.015 | 0.064 | 0.013, 0.115 | 0.013 | |
a Dependent and independent variables were log-transformed before analysis; b All models were adjusted by sex, age and race/ethnicity; c Final adjusted R-squared. Interaction term: BsmI x vitamin E (p = 0.453); BsmI x total cholesterol (p = 0.740).
Association of Vitamin D receptor (VDR) BsmI gene polymorphism with metabolic parameters (Acrelândia, Brazil, 2007–2009).
| VDR BsmI Gene Polymorphism | |||||||
|---|---|---|---|---|---|---|---|
| Variables | Adjusted β-Coefficient a | 95% CI | Fully Adjusted β-Coefficient b | 95% CI | |||
| Insulin concentration | 0.095 | −0.028; 0.218 | 0.168 | 0.104 | −0.008; 0.216 | 0.319 | 0.323 |
| HOMA-IR | 0.110 | −0.020; 0.242 | 0.170 | 0.122 | 0.002; 0.243 | 0.316 | 0.336 |
| Glucose (mg/dL) | 1.502 | 0.064; 2.940 | 0.101 | 1.696 | 0.259; 3.133 | 0.113 | 0.591 |
| Systolic blood pressure (mmHg) | −0.667 | −2.421; 1.085 | 0.020 | −0.646 | −2.413; 1.119 | 0.021 | 0.625 |
| Diastolic blood pressure (mmHg) | −0.180 | −1.402; 1.042 | 0.012 | −0.125 | −1.362; 1.111 | 0.003 | 0.678 |
| 25-hydroxyvitamin D (nmol/L) | 0.007 | −0.059; 0.073 | 0.012 | 0.100 | −0.056; 0.076 | 0.001 | -- |
VDR BsmI polymorphism was coded additively for the minor allele. HOMA-IR: homeostasis model assessment index of insulin resistance. p values were calculated using linear regression models. Insulin levels, HOMA-IR and 25-hydroxyvitamin D were log-transformed before analysis. a Model was adjusted for age, sex and race/ethnicity; b Model was adjusted for age, sex, race/ethnicity, BMI-for-age Z-scores, Tanner stage and baseline household wealth; models for systolic and diastolic blood pressure were additionally adjusted for the child’s height.